Cellexus Biosystems appoints Dr Julie Bick as its US-based Chief Scientific Officer
Cellexus Biosystems PLC announced that it has appointed Dr Julie Bick as its Chief Scientific Officer. Dr Bick has the world-wide responsibility for leading the Company's research and customer support programmes and will be based in the US from its wholly own subsidiary, Cellexus Biosystems Inc..
Dr Bick is a biochemist with expertise in cell culture and has worked in the areas of protein therapeutics, protein engineering and assay platform development. Prior to joining Cellexus Biosystems, Dr Bick was a Senior Scientist (group leader) at Sanofi-Aventis in New Jersey where she was responsible for development protein expression systems (bacterial, yeast and mammalian cell lines), for the large-scale production of pharmaceutically relevant proteins and the generation of transgenic human tissue culture cells for the analysis of protein-protein interactions.
Dr Bick has also held research positions at: UT South Western Medical Centre (Dallas, TX), Syngenta, Torrey Mesa Research Institute (San Diego, CA), AgBiotech Centre, Rutgers University (NJ), and has a Ph.D from Southampton University (United Kingdom).
Other news from the department people
